---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285095767.md"
description: "Assertio Holdings shares are trading higher after the company announced it entered into an Amended and Restated Agreement and Plan of Merger with Garda Therapeutics pursuant to which Garda has increased its offer to acquire all outstanding shares of Assertio to $21.80 per share in cash with no contingent value right."
datetime: "2026-05-04T15:28:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285095767.md)
  - [en](https://longbridge.com/en/news/285095767.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285095767.md)
generator: "portal-rs"
---

# 

Assertio Holdings shares are trading higher after the company announced it entered into an Amended and Restated Agreement and Plan of Merger with Garda Therapeutics pursuant to which Garda has increased its offer to acquire all outstanding shares of Assertio to $21.80 per share in cash with no contingent value right.

### Related Stocks

- [ASRT.US](https://longbridge.com/en/quote/ASRT.US.md)
- [GRTX.US](https://longbridge.com/en/quote/GRTX.US.md)

## Related News & Research

- [Garda To Acquire Assertio For $21.80/shr](https://longbridge.com/en/news/285075626.md)
- [BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatment](https://longbridge.com/en/news/296376333.md)
- [Here’s How Much You Would Have Made Owning ITT Stock In The Last 20 Years](https://longbridge.com/en/news/296845639.md)
- [nVent to Acquire Maverick Power | NVT Stock News](https://longbridge.com/en/news/296774192.md)
- [Workday stock is downgraded after buyout report as growth expectations are 'too optimistic'](https://longbridge.com/en/news/296104750.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**